Inhibition of mammalian 15-lipoxygenase-dependent lipid peroxidation in low-density lipoprotein by quercetin and quercetin monoglucosides

Archives of Biochemistry and Biophysics
E Luiz da SilvaJ Terao

Abstract

Lipoxygenase is suggested to be involved in the early event of atherosclerosis by inducing plasma low-density lipoprotein (LDL) oxidation in the subendothelial space of the arterial wall. Since flavonoids such as quercetin are recognized as lipoxygenase inhibitors and they occur mainly in the glycoside form, we assessed the effect of quercetin and its glycosides (quercetin 3-O-beta-glucopyranoside, Q3G; quercetin 4'-O-beta-glucopyranoside, Q4'G; quercetin 7-O-beta-glucopyranoside, Q7G) on rabbit reticulocyte 15-lipoxygenase (15-LOX)-induced human LDL lipid peroxidation and compared it with the inhibition obtained by ascorbic acid and alpha-tocopherol, the main water-soluble and lipid-soluble antioxidants in blood plasma, respectively. Quercetin inhibited the formation of cholesteryl ester hydroperoxides (CE-OOH) and endogenous alpha-tocopherol consumption effectively throughout the incubation period of 6 h. Ascorbic acid exhibited an effective inhibition only in the initial stage and LDL preloaded with fivefold alpha-tocopherol did not affect the formation of CE-OOH compared with the native LDL. CE-OOH formation was inhibited by both quercetin and quercetin monoglucosides in a concentration-dependent manner. Quercetin, Q3G, and...Continue Reading

References

Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S Ylä-HerttualaD Steinberg
Jun 1, 1990·Biochemical Pharmacology·C V de WhalleyD S Leake
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S ParthasarathyD Steinberg
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B FreiB N Ames
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·B FreiB N Ames
Mar 1, 1987·Biochemical Pharmacology·C G FragaA Boveris
Nov 25, 1985·FEBS Letters·P ReddannaC C Reddy
Oct 31, 1983·Biochemical and Biophysical Research Communications·T YoshimotoS Watanabe-Kohno
Aug 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·G TamuraB N Ames
Dec 1, 1995·The American Journal of Clinical Nutrition·P C HollmanM B Katan
Jul 1, 1995·The Journal of Clinical Investigation·V A FolcikM K Cathcart
Jun 1, 1994·The Journal of Experimental Medicine·H KühnS Wohlfeil
Apr 1, 1993·European Journal of Biochemistry·J BelknerH Kühn
Feb 24, 1996·BMJ : British Medical Journal·P KnektJ Maatela
Jan 1, 1996·Free Radical Biology & Medicine·S A van AckerA Bast
Jan 1, 1996·Free Radical Biology & Medicine·C A Rice-EvansG Paganga
Jan 1, 1996·Free Radical Biology & Medicine·P C HollmanM B Katan
Jan 13, 1997·FEBS Letters·G Paganga, C A Rice-Evans

❮ Previous
Next ❯

Citations

Jun 13, 2002·Critical Reviews in Food Science and Nutrition·Jess Reed
Jun 21, 2003·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Nelson BracescoElia Nunes
Feb 9, 2013·Lipids in Health and Disease·Rafael de Lima PortellaFelix Alexandre Antunes Soares
Apr 8, 1999·Bioscience, Biotechnology, and Biochemistry·T Kaneko, N Baba
Feb 15, 2002·Biological Chemistry·T ScheweH Sies
Jan 12, 2008·Journal of Clinical Biochemistry and Nutrition·Keiko AzumaJunji Terao
Nov 13, 2015·Expert Opinion on Therapeutic Patents·Hamid Sadeghian, Atena Jabbari
Jul 5, 2005·Expert Opinion on Investigational Drugs·P Holvoet
Nov 11, 2008·Life Sciences·Rafael de Lima PortellaFélix Alexandre Antunes Soares
Nov 27, 2004·The Journal of Pharmacy and Pharmacology·Zai-Qun LiuShu-Ying Liu
Jun 30, 2007·Clinical and Experimental Pharmacology & Physiology·Norihiko FunaguchiHisayoshi Fujiwara
Mar 7, 2006·Chemico-biological Interactions·Hester van der WoudeIvonne M C M Rietjens
May 31, 2011·Life Sciences·Rômulo Pillon BarcelosNilda Vargas Barbosa
Jun 21, 2002·Annals of the New York Academy of Sciences·Michael Aviram, Bianca Fuhrman
Sep 22, 2009·Magnetic Resonance in Chemistry : MRC·Edilene Delphino RodriguesGil Valdo José da Silva
Jul 8, 2016·Journal of Cardiovascular Pharmacology·Anandita BasuRupak Mukhopadhyay
Feb 15, 2001·Current Opinion in Lipidology·B Fuhrman, M Aviram
Aug 12, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·J H MoonJ Terao
Jul 27, 2017·Bulletin of Experimental Biology and Medicine·M V BibikovaYu N Korystov
Dec 19, 2000·Free Radical Biology & Medicine·A J DayG Williamson
Nov 28, 2002·Pharmacology & Therapeutics·Bent H Havsteen
Mar 12, 2003·Biochemical Pharmacology·Christian David SadikTankred Schewe
Jul 3, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Matheus Mülling Dos SantosNilda de Vargas Barbosa
Oct 14, 2010·Chemical Reviews·Zai-Qun Liu
Feb 15, 2011·Journal of Agricultural and Food Chemistry·Mon-Yuan YangChau-Jong Wang
Apr 29, 2008·Atherosclerosis·Andreza Fabro de BemJoão Batista Teixeira Rocha
Mar 7, 2002·Journal of Agricultural and Food Chemistry·Keiko AzumaJunji Terao
Feb 20, 2003·Journal of Agricultural and Food Chemistry·Sheng-Yang WangLie-Fen Shyur

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.